A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 Diabetics

NCT00240370 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1159

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Muraglitazar

Sponsor

Bristol-Myers Squibb